This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Scientific Program Partner

Meeting agenda created in conjunction with The Antibody Society.

December 15 - 18, 2024
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 18, 2024

THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS

The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more...

Register your interest for the 2024 event to get first access to the agenda!

Call for Speakers

Submit your speaker proposal by April 26th

We are looking for presentations in the following topic areas:

  • Antibody Discovery and Selection
  • Emerging Library and Display Technologies
  • Quantitative Systems Pharmacology for Antibody Drugs
  • Antibody Therapies for Neurodegenerative Diseases
  • Machine Learning and AI in Antibody Discovery
  • Antibody-Based Degraders for Therapeutic Development
  • Antibody-Drug Conjugates: Clinical Lessons Learned
  • Antibody Drugs in the Clinic & Clinical Translation
  • Novel Bispecific & Multi-Specific Antibodies
  • Combination Antibody Therapies
  • Radiolabeled Antibodies
  • Antibody Repertoires & New Approaches for Antigen Discovery
  • Fc Engineering to Improve Therapeutic Effects
  • Antibody & Protein Engineering in Cell Therapy Applications
  • mRNA Delivery of Antibodies
  • Weird”/Unusual Antibodies for Therapeutic Applications

Michael Kierny, PhD

Scientist I

AstraZeneca

With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

About the Antibody Society

The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.

Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee. 

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Contact Blake Shuka: BShuka@informaconnectls.com

Vaishali Kapoor

Instructor

Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.